Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Puig Vilanova, Ester ^a,b   Ausin, Pilar ^a,b   Martinez Llorens, Juana ^a,b   Gea, Joaquim ^a,b   Barreiro, Esther ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; FIBRINOGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 6; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 486; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; SIRTUIN 1; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNCLASSIFIED DRUG; HDAC4 PROTEIN, HUMAN; HISTONE DEACETYLASE; REPRESSOR PROTEIN;

ACETYLATION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA METHYLATION; EPIGENETICS; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MUSCLE CELL; MUSCLE STRENGTH; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; VASTUS LATERALIS MUSCLE; BODY COMPOSITION; CASE CONTROL STUDY; COMPLICATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SUMOYLATION;

ACETYLATION; AGED; BODY COMPOSITION; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FORCED EXPIRATORY VOLUME; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; MICRORNAS; MIDDLE AGED; MUSCLE WEAKNESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; REPRESSOR PROTEINS; SEVERITY OF ILLNESS INDEX; SUMOYLATION;

EID: 84904251083     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102296     Document Type: Article

References (56)

1. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, et al. (2002) Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 809-813.
2. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, et al. (2010) The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 36: 81-88. 09031936.00104909 [pii];10.1183/09031936. 00104909 [doi].
3. Slot IG, van den Borst B, Hellwig VA, Barreiro E, Schols AM, et al. (2014) The Muscle Oxidative Regulatory Response to Acute Exercise Is Not Impaired in Less Advanced COPD Despite a Decreased Oxidative Phenotype. PLoS One 9: e90150. 10.1371/journal.pone.0090150 [doi];PONE-D-13-41230 [pii].
4. van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, et al. (2013) Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol (1985) 114: 1319-1328. japplphysiol.00508.2012 [pii];10.1152/japplphysiol.00508.2012 [doi].
5. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, et al. (2005) Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 1116-1124. 200407-887OC [pii];10.1164/rccm.200407-887OC [doi].
6. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, et al. (2008) Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63: 100-107. (Pubitemid 351236469)
7. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, et al. (2010) Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182: 477-488.
8. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, et al. (2003) Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1664-1669. (Pubitemid 36760681)
9. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, et al. (2007) Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 261-269. (Pubitemid 47195876)
10. Fermoselle C, Rabinovich R, Ausin P, Puig-Vilanova E, Coronell C, et al. (2012) Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J 40: 851-862. 09031936.00137211 [pii];10.1183/09031936. 00137211 [doi].
11. Gea J, Agusti A, Roca J (2013) Pathophysiology of muscle dysfunction in COPD. J Appl Physiol 114: 1222-1234. japplphysiol.00981.2012 [pii];10.1152/japplphysiol.00981.2012 [doi].
12. Puente-Maestu L, Lazaro A, Tejedor A, Camano S, Fuentes M, et al. (2011) Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 66: 121-127. thx.2010.153031 [pii];10.1136/thx.2010.153031 [doi].
13. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, et al. (2014) An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 189: e15-e62. 10.1164/rccm.201402-0373ST [doi].
14. Gayan-Ramirez G, Decramer M (2013) Mechanisms of striated muscle dysfunction during acute exacerbations of COPD. J Appl Physiol 114: 1291-1299. japplphysiol.00847.2012 [pii];10.1152/japplphysiol.00847.2012 [doi].
15. Hussain SN, Sandri M (2013) Role of autophagy in COPD skeletal muscle dysfunction. J Appl Physiol 114: 1273-1281. japplphysiol.00893.2012 [pii];10.1152/japplphysiol.00893.2012 [doi].
16. Puente-Maestu L, Lazaro A, Humanes B (2013) Metabolic derangements in COPD muscle dysfunction. J Appl Physiol 114: 1282-1290. japplphysiol.00815.2012 [pii];10.1152/japplphysiol.00815.2012 [doi].
17. Sancho-Munoz A, Trampal C, Pascual S, Martinez-Llorens J, Chalela R, et al. (2013) Muscle Glucose Metabolism in Chronic Obstructive Pulmonary Disease Patients. Arch Bronconeumol. S0300-2896(13)00344-X [pii];10.1016/j.arbres.2013. 10.011 [doi].
18. Barreiro E, Sznajder JI (2013) Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction. J Appl Physiol 114: 1263-1272. japplphysiol.01027.2012 [pii];10.1152/japplphysiol.01027.2012 [doi].
19. Donaldson A, Natanek SA, Lewis A, Man WD, Hopkinson NS, et al. (2013) Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax 68: 1140-1149. thoraxjnl-2012-203129 [pii];10.1136/thoraxjnl-2012-203129 [doi].
20. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, et al. (2012) Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 67: 26-34. thoraxjnl-2011-200309 [pii];10.1136/thoraxjnl-2011-200309 [doi].
21. Natanek SA, Riddoch-Contreras J, Marsh GS, Hopkinson NS, Man WD, et al. (2011) Yin Yang 1 expression and localisation in quadriceps muscle in COPD. Arch Bronconeumol 47: 296-302. S0300-2896(11)00090-1 [pii];10.1016/j.arbres.2011.02. 015 [doi].
22. McCarthy JJ, Esser KA (2007) MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Physiol 102: 306-313. 00932.2006 [pii];10.1152/japplphysiol.00932.2006 [doi].
23. McCarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE (2009) Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 39: 219-226. 00042.2009 [pii];10.1152/physiolgenomics.00042.2009 [doi].
24. Nakajima N, Takahashi T, Kitamura R, Isodono K, Asada S, et al. (2006) MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochem Biophys Res Commun 350: 1006-1012. S0006-291X(06)02195-4 [pii];10.1016/j.bbrc.2006.09.153 [doi].
25. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, et al. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117: 2459-2467. 10.1172/JCI31960 [doi]. (Pubitemid 47494347)
26. Wang L, Zhou L, Jiang P, Lu L, Chen X, et al. (2012) Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 20: 1222-1233. mt201235 [pii];10.1038/mt.2012.35 [doi].
27. Taylor SM, Jones PA (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17: 771-779. 0092-8674(79)90317-9 [pii].
28. Alamdari N, Smith IJ, Aversa Z, Hasselgren PO (2010) Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 299: R509-R520. ajpregu.00858.2009 [pii];10.1152/ajpregu.00858.2009 [doi].
29. Alamdari N, Aversa Z, Castillero E, Hasselgren PO (2013) Acetylation and deacetylation-novel factors in muscle wasting. Metabolism 62: 1-11. S0026-0495(12)00121-7 [pii];10.1016/j.metabol.2012.03.019 [doi].
30. Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, et al. (2007) An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 25: 151-159. S1097-2765(06)00844-6 [pii];10.1016/j.molcel.2006.12.008 [doi].
31. Seigneurin-Berny D, Verdel A, Curtet S, Lemercier C, Garin J, et al. (2001) Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol 21: 8035-8044. 10.1128/MCB.21.23.8035-8044.2001 [doi]. (Pubitemid 33051794)
32. Andreou AM, Tavernarakis N (2009) SUMOylation and cell signalling. Biotechnol J 4: 1740-1752. 10.1002/biot.200900219 [doi].
33. Kudryashova E, Kramerova I, Spencer MJ (2012) Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H. J Clin Invest 122: 1764-1776. 59581 [pii];10.1172/JCI59581 [doi].
34. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, et al. (2012) Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol 48: 247-257. S0300-2896(12)00115-9 [pii];10.1016/j.arbres.2012.04.001 [doi].
35. Miravitlles M, Calle M, Soler-Cataluna JJ (2012) Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol 48: 86-98. S0300-2896(11)00342-5 [pii];10.1016/j.arbres.2011.10.007 [doi].
36. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, et al. (2014) Spanish Guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 50 Suppl 1: 1-16. S0300-2896(14)70070-5 [pii];10.1016/S0300-2896(14)70070-5 [doi].
37. Rieger-Reyes C, Garcia-Tirado FJ, Rubio-Galan FJ, Marin-Trigo JM (2013) Classification of Chronic Obstructive Pulmonary Disease Severity According to the New Global Initiative for Chronic Obstructive Lung Disease 2011 Guidelines: COPD Assessment Test Versus Modified Medical Research Council Scale. Arch Bronconeumol. S0300-2896(13)00306-2 [pii];10.1016/j.arbres.2013.09.014 [doi].
38. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, et al. (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22: 217-224. (Pubitemid 16116729)
39. Roca J, Rodriguez-Roisin R, Cobo E, Burgos F, Perez J, et al. (1990) Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 141: 1026-1032. (Pubitemid 20157736)
40. Roca J, Burgos F, Barbera JA, Sunyer J, Rodriguez-Roisin R, et al. (1998) Prediction equations for plethysmographic lung volumes. Respir Med 92: 454-460. (Pubitemid 28162154)
41. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, et al. (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62: 115-120.
42. Andreu AL, Martinez R, Marti R, Garcia-Arumi E (2009) Quantification of mitochondrial DNA copy number: pre-analytical factors. Mitochondrion 9: 242-246. S1567-7249(09)00039-7 [pii];10.1016/j.mito.2009.02.006 [doi].
43. Hadoux J, Favier J, Scoazec JY, Leboulleux S, Al GA, et al. (2014) SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. Int J Cancer. 10.1002/ijc.28913 [doi].
44. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. 10.1006/meth.2001.1262 [doi];S1046-2023(01)91262-9 [pii].
45. Barreiro E, Rabinovich R, Marin-Corral J, Barbera JA, Gea J, et al. (2009) Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64: 13-19.
46. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, et al. (2009) Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 33: 1309-1319.
47. Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, et al. (2011) Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111: 808-817. japplphysiol.01017.2010 [pii];10.1152/japplphysiol.01017.2010 [doi].
48. Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, et al. (2004) Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 169: 1022-1027. (Pubitemid 38543641)
49. Ortega F, Toral J, Cejudo P, Villagomez R, Sanchez H, et al. (2002) Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 669-674. 10.1164/rccm.2107081 [doi]. (Pubitemid 34971848)
50. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, et al. (2012) Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 40: 1115-1122. 09031936.00170111 [pii];10.1183/09031936.00170111 [doi].
51. Gagnon P, Lemire BB, Dube A, Saey D, Porlier A, et al. (2014) Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respir Res 15: 4. 1465-9921-15-4 [pii];10.1186/1465-9921-15-4 [doi].
52. Perdiguero E, Sousa-Victor P, Ballestar E, Munoz-Canoves P (2009) Epigenetic regulation of myogenesis. Epigenetics 4: 541-550. 10258 [pii].
53. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, et al. (2009) Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120: 2377-2385. CIRCULATIONAHA.109.879429 [pii];10.1161/CIRCULATIONAHA.109.879429 [doi].
54. Sadoul K, Boyault C, Pabion M, Khochbin S (2008) Regulation of protein turnover by acetyltransferases and deacetylases. Biochimie 90: 306-312. S0300-9084(07)00168-X [pii];10.1016/j.biochi.2007.06.009 [doi].
55. Schakman O, Gilson H, Kalista S, Thissen JP (2009) Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 72 Suppl 1: 36-41. 000229762 [pii];10.1159/000229762 [doi].
56. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, et al. (2012) Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med 52: 88-94.